Heart Failure Slashes Exercise Capacity in Older Adults and Worsens With Age
A meta-analysis of 38 studies reveals older heart failure patients have dramatically lower peak oxygen uptake than controls, declining further with each decade.
Summary
A systematic review and meta-analysis published in Geroscience analyzed 38 studies to quantify how heart failure (HF) impairs peak oxygen uptake (VO₂peak) in older adults. Researchers found that older HF patients averaged nearly 9 mL/kg/min lower VO₂peak compared to age-matched controls — a clinically significant gap reflecting both cardiac output and heart rate deficits. Importantly, the decline did not plateau: VO₂peak fell progressively from the young-old (60–69), to middle-old (70–79), to oldest-old (80+) groups. These findings highlight the compounding burden of aging and heart failure on cardiorespiratory fitness, with direct implications for exercise prescription, prognosis, and rehabilitative care in an aging population.
Detailed Summary
Cardiorespiratory fitness, measured as peak oxygen uptake (VO₂peak), is one of the strongest predictors of mortality and quality of life in both aging and heart failure. Yet despite the growing prevalence of HF in older adults, robust data on VO₂peak specifically in elderly HF populations had been limited — until now.
This systematic review and meta-analysis searched PubMed from 1967 through May 2024, screening 2,788 articles and ultimately including 38 studies. The research had two aims: first, to compare VO₂peak between older HF patients (mean age ≥65) and healthy controls; second, to examine how VO₂peak differs across three older age subgroups — young-old (60–69), middle-old (70–79), and oldest-old (≥80).
The headline finding is striking: older HF patients showed a weighted mean difference of −8.8 mL/kg/min in VO₂peak compared to controls (95% CI: −10.3 to −7.3). This represents a profound functional impairment. In the subset of studies reporting Fick determinants, both peak cardiac output and peak heart rate were significantly reduced in HF patients, pointing to central cardiovascular mechanisms driving the deficit.
Equally important was the age-gradient finding: VO₂peak declined progressively across older age subgroups, dropping ~1.5 mL/kg/min from young-old to middle-old, and another ~1.2 mL/kg/min from middle-old to oldest-old. This suggests the combined toll of aging and HF is cumulative and unrelenting.
Clinically, these results underscore the urgency of early and sustained exercise rehabilitation in older HF patients, and the need for age-stratified VO₂peak reference values. Caveats include reliance on aggregate data, potential heterogeneity across HF subtypes, and the fact that only 38 studies met inclusion criteria from decades of literature.
Key Findings
- Older HF patients had VO₂peak nearly 8.8 mL/kg/min lower than age-matched controls across 30 studies.
- Peak cardiac output and heart rate were both significantly reduced in HF patients versus controls.
- VO₂peak declined ~1.5 mL/kg/min from young-old (60–69) to middle-old (70–79) HF patients.
- A further ~1.2 mL/kg/min drop was observed from middle-old to oldest-old (≥80) HF patients.
- 38 studies from 2,788 screened met inclusion criteria, including over 2,000 total participants.
Methodology
This was a systematic review and meta-analysis using random-effects models, searching PubMed from 1967 to May 2024. Inclusion required HF patients with mean age ≥65, VO₂peak measured via maximal cardiopulmonary exercise testing, and a control group for the primary aim. Results were reported as weighted mean differences with 95% confidence intervals.
Study Limitations
The analysis is based on aggregate study-level data, limiting individual-level insights such as HF subtype (HFrEF vs. HFpEF) breakdowns across all aims. Heterogeneity in study designs, exercise testing protocols, and patient populations may influence the pooled estimates. The relatively small number of studies (8) available for the age-subgroup analysis limits the precision of decade-by-decade comparisons.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.
Enter your email to subscribe: